Meridia 5 mg Capsules: Understanding the Historical Product

Meridia 5 mg capsules were a historical formulation of Meridia, the brand name associated with the active ingredient sibutramine. FDA materials identify Meridia as a sibutramine product and document a 5 mg capsule formulation. However, Meridia is no longer approved for use in the United States following its withdrawal in 2010.

What Were Meridia Capsules?

Meridia was supplied as an oral prescription medication. Historical FDA materials show Meridia 5 mg capsules and identify sibutramine hydrochloride monohydrate as the active ingredient.

The capsule format was designed for oral administration under prescription supervision.

What Was the Purpose of the 5 mg Formulation?

The 5 mg strength was part of the product's historical dosage range. Different strengths allowed physicians to consider treatment according to the prescribing information available at the time.

However, the existence of a particular strength does not mean that the product remains appropriate or approved today.

Why Did the Product Leave the U.S. Market?

The withdrawal was related to cardiovascular safety.

FDA information states that sibutramine was associated with an increased risk of heart attack and stroke, leading to the removal of Meridia from the U.S. market.

The SCOUT study also found increased rates of major cardiovascular events in the high-risk population receiving sibutramine.

Why Product Identification Matters?

When researching an older medication, identifying the exact product is important. Brand name, active ingredient, strength, and regulatory status can all affect how information should be interpreted.

For Meridia, the relationship is straightforward:

• Brand: Meridia
• Active ingredient: sibutramine
• Historical strength: 5 mg among other strengths
• U.S. status: approval withdrawn in 2010

FDA documentation supports these historical details.

Be Cautious With Online Capsules

The FDA has repeatedly warned about products marketed for weight loss that contain undeclared sibutramine. Such products may not provide reliable information about their ingredients, strength, quality, or safety.

Consumers should therefore avoid assuming that an online listing using the Meridia name represents an FDA-approved U.S. medicine.

Conclusion

Meridia 5 mg capsules were part of the historical Meridia product line containing sibutramine. Although the medication was once approved for obesity treatment in the United States, its approval was withdrawn in 2010 because of cardiovascular safety concerns.

For further product information and reference material, visit Careskit. Current medication decisions should always be based on up-to-date regulatory and medical guidance.